Authors: Esmee Dijkstra1, Geke Hospers1, Cornelis van de Velde2, Joke Fleer3, Renu Bahadoer2, Marianne Guren4, Jolien Tjalma5, Hein Putter6, Elma Meershoek-Klein Kranenbarg2, Annet Roodvoets2, Albert ten Tije7, Jaume Capdevila8, Mathijs Hendriks9, Andres Cervantes10, Per Nilsson11, Bengt Glimelius12, Boudewijn van Etten13, Corrie Marijnen14,15
1University Medical Center Groningen, Medical Oncology, Groningen, The Netherlands; 2Leiden University Medical Center, Surgery, Leiden, The Netherlands; 3University Medical Center Groningen, Health Sciences, Groningen, The Netherlands; 4Oslo University Hospital, Oncology, Oslo, Norway; 5University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands; 6Leiden University Medical Center, Biomedical Datasciences, Leiden, The Netherlands; 7Amphia Hospital, Medical Oncology, Breda, The Netherlands; 8Vall Hebron University Hospital and Vall Hebron Institute of oncology, Medical Oncology, Barcelona, Spain; 9Northwest Clinics, Medical Oncology, Alkmaar, The Netherlands; 10Biomedical Research Institute Incliva, University of Valencia, Medical Oncology, Valencia, Spain; 11Karolinska University Hospital, Surgery, Stockholm, Sweden; 12Uppsala University, Immunology, genetics and pathology, Uppsala, Sweden; 13University Medical Center Groningen, Surgery, Groningen, The Netherlands; 14Netherlands Cancer Institute, Radiation Oncology, Amsterdam, The Netherlands; 15Leiden University Medical Center, Radiation Oncology, Leiden, The Netherlands
Show Affiliations
Hide Affiliations